Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd.’s Net Profit Rose 26.7% in First Three Quarters of 2023

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd. (通化金马药业集团股份有限公司) (000766.SZ) reported a net profit of 14.9 million yuan in the first three quarters of 2023, up 26.7% year-on-year.

Meanwhile, the company posted 1 billion yuan in revenue, up 3% year-on-year.

At the end of the reporting period, it had 4.5 billion yuan in total assets and 2.1 billion yuan in total liabilities, with a liability-to-asset ratio of 48.1%.